Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the basic domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /srv/www/wordpress/wp-includes/functions.php on line 6114
Endocrinology and Diabetes – Medi-News.in

Category «Endocrinology and Diabetes»

Next-generation CGM with 15-day sensor improves upon previous generation’s accuracy

Next-generation CGM with 15-day sensor improves upon previous generation’s accuracy

A 15-day integrated continuous glucose monitor registered accurate glucose values similar to those measured through venous blood samples, according to a presenter.As Healio previously reported, the Dexcom G7 CGM was cleared in December 2022 for people aged 2 years and older with type 1 and type 2 diabetes. Each sensor for the current-generation device can …

Addressing skin disease with medications alone is ‘not enough,’ diet also brings benefits

Addressing skin disease with medications alone is ‘not enough,’ diet also brings benefits

ORLANDO — Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse events, according to a speaker at the American Academy of Dermatology Annual Meeting.Following the 2025 AAD Annual Meeting, the academy published a press release stating presentations on diet and lifestyle took center stage …

Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes

Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks for adults with type 1 diabetes, according to findings from the INHALE-3 extension trial.As Healio previously reported, technosphere insulin (Afrezza, MannKind Pharma) resulted in noninferior HbA1c changes compared with usual care in adults with type 1 …

Q&A: AMA president discusses fifth straight year of Medicare physician payment cuts

Q&A: AMA president discusses fifth straight year of Medicare physician payment cuts

Physicians treating Medicare patients are staring down the barrel of five consecutive years of cuts to their reimbursement rates.In January, CMS proposed the 2026 reimbursement rates for Medicare Advantage (MA) insurers. From 2025 to 2026, MA plans will likely receive a 4.33% average payment increase — higher than the expected health care inflation rate — …

Biomarkers identified by machine learning could assist in diagnosing liver diseases

Biomarkers identified by machine learning could assist in diagnosing liver diseases

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis, researchers reported.“The current reliance on liver biopsy for diagnosis and a lack of validated biomarkers are major factors contributing to the overall burden of metabolic dysfunction-associated steatotic liver disease (MASLD),” …

Automated insulin delivery provides range of glycemic benefits in type 2 diabetes

Automated insulin delivery provides range of glycemic benefits in type 2 diabetes

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of an automated insulin delivery system compared with standard care, according to findings from a new trial.In the randomized controlled 2IQP trial, presented at the International Conference on Advanced Technologies & Treatments for Diabetes and simultaneously …

Excessive menstrual bleeding may worsen fatigue during menopause transition

Excessive menstrual bleeding may worsen fatigue during menopause transition

Midlife women with repeated episodes of heavy or prolonged menstrual bleeding over 6 months were 40% to 60% more likely to report feeling fatigued, underscoring the clinical importance of menstrual history during the menopause transition.”Despite the increased scientific and media attention to menopausal symptoms, studies of menopause have rarely examined the health consequences of women’s …

Combination GLP-1, hormone therapy may reduce risk for endometrial cancer

Combination GLP-1, hormone therapy may reduce risk for endometrial cancer

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results.Findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed a protective benefit against endometrial cancer for women with certain non-malignant gynecologic conditions.Ting-Tai Yen, MD, instructor in the department of …

Three osteoporosis risk assessment tools underperform in younger postmenopausal women

Three osteoporosis risk assessment tools underperform in younger postmenopausal women

Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a study published in JAMA Network Open.Researchers assessed the performance of the Osteoporosis Self-Assessment Tool, the Osteoporosis Risk Assessment Instrument and the Osteoporosis Index of Risk, which are three of the …

Societies take stand against off-brand GLP-1s over safety concerns

Societies take stand against off-brand GLP-1s over safety concerns

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.In December, the FDA released a statement to health care professionals and patients warning against the use of compounded and counterfeit versions of diabetes and obesity drugs, including semaglutide (Ozempic/Wegovy, Novo …

Q&A: How adults with type 1 diabetes can become commercial airline pilots

Q&A: How adults with type 1 diabetes can become commercial airline pilots

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just thriving in the air, but also with their diabetes management.In November 2019, a change to Federal Aviation Administration regulations permitted people with insulin-treated type 1 diabetes to receive first-class and second-class medical certificates, allowing …

Obesity and diabetes: Understanding the global surge and how to solve it

Obesity and diabetes: Understanding the global surge and how to solve it

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care systems.Gaining a comprehensive understanding of the causes and implications of these conditions is essential for developing effective prevention and management strategies.The global rise in obesity and diabetes can be attributed to several interconnected factors:First among them are …

Oz faces senators’ questions on cuts, calls CMS nomination a ‘monumental opportunity’

Oz faces senators’ questions on cuts, calls CMS nomination a ‘monumental opportunity’

Senators questioned Mehmet Oz, MD, MBA, on Medicaid budget cuts, nursing shortages and his prior claims about miracle drugs during a committee hearing to be the next administrator of CMS.“Dr. Oz,” a surgeon, professor emeritus of cardiothoracic surgery at Columbia University and former television personality, has been nominated by President Donald J. Trump to head …

Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits

Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and phentermine/topiramate, but their estimated net price is too high for them to be cost-effective, researchers reported.In findings from a microsimulation model published in JAMA Health Forum, semaglutide (Wegovy, Novo Nordisk) had the highest incremental cost-effectiveness ratio (ICER) of four obesity medications assessed in …

GLP-1 drugs may extend life, graft survival for kidney transplant recipients with diabetes

GLP-1 drugs may extend life, graft survival for kidney transplant recipients with diabetes

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with improved long-term graft survival and overall survival, according to study data.In a retrospective cohort study, Babak J. Orandi, MD, PhD, associate professor in the departments of surgery and medicine at NYU Grossman School of Medicine and NYU Langone …

Intentional weight loss of 5% or more cuts risk for death among postmenopausal women

Intentional weight loss of 5% or more cuts risk for death among postmenopausal women

Intentional weight loss of 5% or more, coupled with reduced waist circumference was associated with lower risk for death from cancer, CVD or any cause among postmenopausal women followed for more than 18 years, data show.In a prospective analysis of more than 58,000 women, researchers also found that intentional weight loss without a reduction in …

Bionic pancreas for type 1 diabetes feasible to implement in primary care, telehealth

Bionic pancreas for type 1 diabetes feasible to implement in primary care, telehealth

Adults with type 1 diabetes who initiated treatment with a bionic pancreas at a primary care site experienced similar glycemic benefits as those starting the device through an endocrinologist, researchers reported.In a small study published in Clinical Diabetes, 97% of all adults achieved a continuous glucose monitoring average glucose of less than 183 mg/dL at …

Cocoa extract, multivitamin supplements do not lower fracture risk for older adults

Cocoa extract, multivitamin supplements do not lower fracture risk for older adults

Multivitamin and cocoa extract supplements do not protect against clinical fractures for older adults, according to data published in the Journal of Bone and Mineral Research.As Healio previously reported, the Cocoa Supplement and Multivitamin Outcomes Study (COSMOS) randomly assigned 21,442 adults aged 60 years and older participating in the Women’s Health Initiative extension study or …

GLP-1 agonists may be protective against hip fracture in patients with type 2 diabetes

GLP-1 agonists may be protective against hip fracture in patients with type 2 diabetes

SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here.“This study supports other studies showing that GLP-1s can have a positive effect on bone mineral density by showing that patients that are treated with these have a lower incidence of …

Testosterone therapy significantly improves sexual desire in older men with prediabetes

Testosterone therapy significantly improves sexual desire in older men with prediabetes

Testosterone therapy plus lifestyle intervention was tied to a larger improvement in sexual desire than lifestyle intervention alone among older men with impaired glucose tolerance, according to a secondary analysis of the T4DM trial.As Healio previously reported, the T4DM trial randomly assigned 1,007 men aged 50 to 74 years with a waist circumference of 95 …

Hormone therapy use, duration not tied to brain tumor risk for menopausal women

Hormone therapy use, duration not tied to brain tumor risk for menopausal women

Among menopausal women, hormone therapy use and duration were not associated with brain malignancy risk, although researchers cautioned that more research is needed, according to findings published in Menopause.“The widespread use of HT is evident, with an estimated 600 million woman-years of HT usage recorded in Western countries over the past 50 years, beginning in …

CagriSema confers 15.7% weight loss at 68 weeks for adults with obesity, type 2 diabetes

CagriSema confers 15.7% weight loss at 68 weeks for adults with obesity, type 2 diabetes

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost 15.7% of their body weight at 68 weeks, according to topline data from the REDEFINE 2 trial.As Healio previously reported in December, CagriSema (Novo Nordisk) conferred a 22.7% weight loss at 68 weeks among adults with obesity …

Q&A: ‘Normal’ blood glucose may still increase risk for heart disease

Q&A: ‘Normal’ blood glucose may still increase risk for heart disease

Slightly elevated blood glucose within a range of what is generally considered “normal” may be associated with increased risk for heart disease, researchers reported.Gregg C. Fonarow, MD, FACC, FAHA, FHFSA, director of the Ahmanson-UCLA Cardiomyopathy Center, co-director of the UCLA Preventive Cardiology Program, co-chief of the division of cardiology at UCLA and Eliot Corday Chair …

NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain

NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the medication through a new Novo Nordisk direct-to-consumer program.In a March 5 press release, Novo Nordisk announced the launch of NovoCare Pharmacy, a direct-to-patient program that will provide any available dose of Wegovy (semaglutide, …

Makary vows FDA will uphold ‘gold standard of trusted science’ during senate hearing

Makary vows FDA will uphold ‘gold standard of trusted science’ during senate hearing

Key takeaways:Lawmakers grilled Martin Makary, MD, MPH, on transparency, his plans for mifepristone and his stance on the recently cancelled Vaccine Advisory Committee meeting during Thursday’s senate hearing to be the next FDA commissioner.Makary, a surgeon and public policy researcher at Johns Hopkins University, has been nominated to be the agency’s next leader under the …

Thyroid cancer incidence plateaued during 2010s after rising from 1975 to 2009

Thyroid cancer incidence plateaued during 2010s after rising from 1975 to 2009

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings published in The Lancet Diabetes & Endocrinology.In a retrospective analysis of data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) and National Center for Health Statistics databases, researchers found no changes in …